Cross Marketing Group Inc. Logo

Cross Marketing Group Inc.

Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.

3675 | T

Overview

Corporate Details

ISIN(s):
JP3272760004
LEI:
Country:
Japan
Address:
新宿区西新宿三丁目20番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Established in 2003, Cross Marketing Group Inc. is a comprehensive marketing solutions provider specializing in market research, digital marketing, and data marketing. The company offers a one-stop service for both qualitative and quantitative research, with a core focus on online methodologies. Leveraging one of Japan's largest consumer research panels, it delivers actionable insights to support client decision-making for product development and strategy. The Group's services also encompass a wide range of digital marketing and data-driven solutions, assisting clients in their digital transformation (DX) and marketing process optimization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:33
Regulatory News Service
確認書
Japanese 8.9 KB
2025-09-24 08:32
Annual Report
有価証券報告書-第13期(2024/07/01-2025/06/30)
Japanese 1.5 MB
2025-06-24 09:01
Share Issue/Capital Change
臨時報告書
Japanese 33.6 KB
2025-03-04 02:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-02-14 08:03
Report Publication Announcement
確認書
Japanese 9.0 KB
2025-02-14 08:02
Interim Report
半期報告書-第13期(2024/07/01-2025/06/30)
Japanese 242.4 KB
2025-02-04 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-01-07 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.2 KB
2024-12-03 03:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.3 KB
2024-11-05 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.5 KB
2024-10-03 08:00
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2024-10-02 05:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.9 KB
2024-09-27 08:06
Governance Information
内部統制報告書-第12期(2023/07/01-2024/06/30)
Japanese 23.5 KB
2024-09-27 08:06
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:05
Annual Report
有価証券報告書-第12期(2023/07/01-2024/06/30)
Japanese 1.5 MB

Automate Your Workflow. Get a real-time feed of all Cross Marketing Group Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cross Marketing Group Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cross Marketing Group Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.